Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Aug;59(7):374-9.
doi: 10.1016/j.biopha.2005.07.003.

Sulfiredoxin: a potential therapeutic agent?

Victoria J Findlay  1 , Haim Tapiero, Danyelle M Townsend
Affiliations
Review

Sulfiredoxin: a potential therapeutic agent?

Victoria J Findlay et al. Biomed Pharmacother. 2005 Aug.

Abstract

The importance of antioxidants in maintaining homeostasis has long been accepted and includes antioxidant proteins such as, peroxiredoxin (Prx), superoxide dismutase and glutathione S transferases. Sulfiredoxin (Srx) is a recently identified antioxidant protein with a role in signaling through catalytic reduction of oxidative modifications. It was first characterized for its regulation of Prx(s) through reduction of the conserved cysteine from sulfinic to sulfenic acid, thereby impacting the role of Prx in regulation of downstream transcription factors and kinase signaling pathways. Furthermore, the reduction of sulfinic to sulfenic acid prevents further oxidation of the conserved cysteine residue to sulfonic acid, the end result of which is degradation. Srx also has a role in the reduction of glutathionylation a post-translational, oxidative modification that occurs on numerous proteins and has been implicated in a wide variety of pathologies, including Parkinson's disease. The regulation of glutathionylation/deglutathionylation (or thiol switch) has been likened to phosphorylation/dephosphorylation, another post-translational modification involved in the regulation of signaling pathways. Unlike, the reduction of Prx over-oxidation, Srx-dependent deglutathionylation appears to be non-specific. Deglutathionylation of multiple proteins has been observed both in vitro and in vivo in response to oxidative and/or nitrosative stress. This review discusses Srx as a novel antioxidant, and focuses on its potential role in the regulation of glutathionylation/deglutathionylation pathways, that have been implicated in a growing number of disease states.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Differential regulation of ASK1 by Trx, Grx and GSTμ. ASK1 is in complex with reduced Trx, Grx and GSTμ and is inactive under basal conditions. ROS/RNS, generated by a plethora of different stresses, leads to the activation of ASK1 through the dissociation of one or another of its small redox molecule inhibitors. The dissociation occurs concurrently with the formation of a disulfide bond with Trx, Grx or GSTμ. The activation of ASK1 results in the activation of a cascade, the end point of which is the initiation of apoptosis or stress response.
Fig. 2.
Fig. 2.
Scheme of cysteine oxidation. The oxidation of a sulfur residue within the amino acid cysteine can result in the formation of a cysteine radical or a sulfenic, sulfinic or sulfonic acid derivative (the latter of which is irreversible). Reduction of the sulfinic to the sulfenic acid derivative in Prx is known to occur through the action of Srx. The oxidation of the sulfur residue in GSH results in the formation of glutathione sulfenate. This reactive molecule can react with a reduced protein cysteine residue (Cys–SH), either directly or indirectly through the formation of glutathione disulfide S-oxide, to form a protein mixed disulfide. Studies have also implicated Srx in the reduction of glutathionylated proteins (Cys–S–SG).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adler V, Yin Z, et al. Regulation of JNK signaling by GSTp. EMBO J 1999;18(5):1321–34. - PMC - PubMed
    1. Aksenov MY, Markesbery WR. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer’s disease. Neurosci Lett 2001;302(2–3): 141–5. - PubMed
    1. Barrett WC, DeGnore JP, et al. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 1999;38(20): 6699–705. - PubMed
    1. Biteau B, Labarre J, et al. ATP-dependent reduction of cysteine–sulphinic acid by S. cerevisiae sulphiredoxin. Nature 2003; 425(6961):980–4. - PubMed
    1. Bozonet SM, Findlay VJ, et al. Oxidation of a eukaryotic 2-cys peroxiredoxin is a molecular switch controlling the transcriptional response to increasing levels of hydrogen peroxide. J Biol Chem 2005;280(24):23319–27. - PubMed

MeSH terms